News

All news

The International Generic and Biosimilar Medicines Association (IGBA), has appointed Ana Gaunt as its new Secretary General with immediate effect, following the decision of Susana Almeida to step...

Sustainable and responsible financing—powered by multisectoral collaboration—is key to meet the needs of people living with or affected by NCDs, including reducing out-of-pocket costs and...

Geneva, January 5, 2026 – The International Generic and Biosimilar Medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, announced today that Jim...

A research report resulting from a collaboration between the University of Maryland and University of Michigan (USA) delivers a critical set of recommendations emphasizing the urgent need for...

On 20 November, the CEO Advisory Committee of the International Generic and Biosimilar Medicines Association (IGBA) convened to discuss how the generics and biosimilars sector can continue to deliver...

At the WHO Global Forum for Public Procurement of Health Products, a powerful reminder was shared by WHO’s Director-General, Dr. Tedros Adhanom Ghebreyesus.

Today marks the launch of Global Biosimilars Week 2025, an international awareness campaign led by the International Generic and Biosimilar Medicines Association (IGBA). This year’s theme,...

IGBA at UNGA Side Events.

The International Generic and Biosimilar medicines Association (IGBA) welcomes the adoption of the WHO Pandemic Agreement at the 78th World Health Assembly in May 2025. This landmark accord...

The IGBA urgently calls for global collaboration among stakeholders to protect the balance between innovation and access to medicines. A thriving off-patent sector is not a threat to innovation —...

The International Generic and Biosimilar medicines Association (IGBA), being the global voice of generic and biosimilar medicines industries, calls for G7 countries to consider health and access to...

The International Generic and Biosimilar medicines Association (IGBA) commends the General Assembly of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for...

Brazilian Association of Generic and Biosimilar Medicines Industries

Brazilian Association of Generic and Biosimilar Medicines Industries

Mexican Association of Generic Medicines

Mexican Association of Generic Medicines

Generic and Biosimilar Medicines Association Australia

Generic and Biosimilar Medicines Association Australia
  1. Bangladesh Association of Pharmaceutical Industries (BAPI)
  2. Association of Generic and Biosimilar Drug Manufacturers for the Republic of Serbia and the Republic of Montenegro

Page 1 of 2

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail: 
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Follow us on: LinkedIn - YouTube

About IGBA